Further Fertility Preservation Techniques
Dittrich R, von Wolff M (2020)
Publication Type: Book chapter / Article in edited volumes
Publication year: 2020
Publisher: Springer Science+Business Media
Edited Volumes: Fertility Preservation in Oncological and Non-Oncological Diseases
City/Town: Cham
Pages Range: 241–250
ISBN: 9783030475680
DOI: 10.1007/978-3-030-47568-0_27
Abstract
Cryopreservation of oocytes and ovarian tissue as well as the administration of GnRH agonists and transposition of the ovaries are well established as fertility preservation methods. In addition, there are alternative techniques that are less well established or still experimental. These techniques include medication to protect the ovaries, such as AS101, CIP and AMH, measures to use the ovarian tissue in patients with leukaemia and other diseases with a high risk of malignant cells in the ovarian tissue such as xenotransplantation, IVG and artificial ovaries, stem cells and uterus transplantation.
Authors with CRIS profile
Involved external institutions
Switzerland (CH)How to cite
APA:
Dittrich, R., & von Wolff, M. (2020). Further Fertility Preservation Techniques. In Michael von Wolff, Frank Nawroth (Eds.), Fertility Preservation in Oncological and Non-Oncological Diseases. (pp. 241–250). Cham: Springer Science+Business Media.
MLA:
Dittrich, Ralf, and Michael von Wolff. "Further Fertility Preservation Techniques." Fertility Preservation in Oncological and Non-Oncological Diseases. Ed. Michael von Wolff, Frank Nawroth, Cham: Springer Science+Business Media, 2020. 241–250.
BibTeX: Download